Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10
- PMID: 22653886
- DOI: 10.1093/pubmed/fds035
Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10
Abstract
Background: Sickle cell disease (SCD) is a rising cause of mortality and morbidity in England and consequently an important policy issue for the National Health Service. There has been no previous study that has examined SCD admission rates in England.
Methods: Data from Hospital Episode Statistics were analysed for all hospital episodes (2001/10) in England with a primary diagnosis of sickle cell anaemia with crisis (D57.0) or without crisis (D57.1). Secondary and tertiary diagnoses were examined among those patients admitted with either of these codes as their primary diagnosis.
Results: The overall SCD admission rate per 100 000 has risen from 21.2 in 2001/02 to 33.5 in 2009/10, a rise of over 50%. London accounts for 74.9% of all SCD admissions in England. 57.9% of patients admitted are discharged within 24 h. The largest rise in admission rates was seen among males aged 40-49 years where admission rates per 100 000 increased from 7.6 to 26.8 over the study period.
Conclusions: Our data show that SCD admissions are rising in England, particularly in London. Over half of patients admitted with SCD were discharged within 24 h, suggesting that some of these admissions could be prevented through better ambulatory care of patients.
Comment in
-
Trends in hospital admissions for sickle cell disease in England.J Public Health (Oxf). 2013 Mar;35(1):178. doi: 10.1093/pubmed/fdt001. Epub 2013 Feb 5. J Public Health (Oxf). 2013. PMID: 23386325 Free PMC article. No abstract available.
-
Trends in hospital admissions for sickle cell disease in England.J Public Health (Oxf). 2013 Mar;35(1):179. doi: 10.1093/pubmed/fdt005. Epub 2013 Feb 5. J Public Health (Oxf). 2013. PMID: 23386327 No abstract available.
Similar articles
-
Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.BMC Clin Pharmacol. 2007 Sep 25;7:9. doi: 10.1186/1472-6904-7-9. BMC Clin Pharmacol. 2007. PMID: 17894876 Free PMC article.
-
Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study.J Public Health (Oxf). 2013 Dec;35(4):510-7. doi: 10.1093/pubmed/fdt100. Epub 2013 Oct 29. J Public Health (Oxf). 2013. PMID: 24169414
-
Hospitalisations for sickle-cell disease in an Australian paediatric population.J Paediatr Child Health. 2013 Jan;49(1):68-71. doi: 10.1111/jpc.12018. Epub 2012 Dec 2. J Paediatr Child Health. 2013. PMID: 23198729
-
Transition from paediatric to adult care for patients with sickle cell disease.Br J Haematol. 2014 Mar;164(5):630-5. doi: 10.1111/bjh.12700. Epub 2013 Dec 17. Br J Haematol. 2014. PMID: 24345037 Review.
-
The comprehensiveness care of sickle cell disease.Eur J Haematol. 2002 Mar;68(3):157-62. doi: 10.1034/j.1600-0609.2002.01523.x. Eur J Haematol. 2002. PMID: 12068796 Review.
Cited by
-
Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).PLoS One. 2020 Jan 29;15(1):e0228399. doi: 10.1371/journal.pone.0228399. eCollection 2020. PLoS One. 2020. PMID: 31995624 Free PMC article.
-
SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt.BMJ Open. 2016 Jun 9;6(6):e011276. doi: 10.1136/bmjopen-2016-011276. BMJ Open. 2016. PMID: 27288381 Free PMC article. Clinical Trial.
-
Views of patients about sickle cell disease management in primary care: a questionnaire-based pilot study.JRSM Short Rep. 2012 Nov;3(11):78. doi: 10.1258/shorts.2012.011173. Epub 2012 Nov 30. JRSM Short Rep. 2012. PMID: 23323196 Free PMC article.
-
Patients' views on improving sickle cell disease management in primary care: focus group discussion.JRSM Short Rep. 2012 Dec;3(12):84. doi: 10.1258/shorts.2012.011153. Epub 2012 Dec 27. JRSM Short Rep. 2012. PMID: 23476727 Free PMC article.
-
Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country.BMC Health Serv Res. 2022 Jan 8;22(1):42. doi: 10.1186/s12913-021-07461-6. BMC Health Serv Res. 2022. PMID: 34998394 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical